Open access
Sep 2026
Targeting tryptophan hydroxylase 1 restricts growth and suppresses plasticity in neuroendocrine prostate cancer.
Findings characterize TPH1's contribution to NEPC and suggest TPH1 as a potential therapeutic target and suggest TPH1 as a potential therapeutic target.
Jing Wei, Jing Wang, Jing-Rui Chen et al.
· Journal of Clinical Investig... · 0 citations